Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.
about
A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational ModificationsHorizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadePerspectives on systems biology applications in diabetic kidney diseaseThe role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal diseaseMolecular mechanisms of diabetic kidney diseaseDiabetic Kidney Disease: Pathophysiology and Therapeutic TargetsSuramin alleviates glomerular injury and inflammation in the remnant kidneyThe tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD miceTemporal profile of the renal transcriptome of HIV-1 transgenic mice during disease progressionNew susceptibility loci associated with kidney disease in type 1 diabetes.Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue.Discovering hidden relationships between renal diseases and regulated genes through 3D network visualizations.SOCS3 overexpression inhibits advanced glycation end product-induced EMT in proximal tubule epithelial cellsBASP1 promotes apoptosis in diabetic nephropathy.Role of transcription factor acetylation in diabetic kidney disease.IL-18 induces profibrotic renal tubular cell injury via STAT3 activation.Mouse models of diabetic nephropathy.Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus.Inflammation in diabetic kidney diseaseUnderstanding kidney disease: toward the integration of regulatory networks across species.Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes.From molecular signatures to predictive biomarkers: modeling disease pathophysiology and drug mechanism of action.Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissueSphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.Transcriptome analysis of human diabetic kidney diseasePaclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.A cis-eQTL in PFKFB2 is associated with diabetic nephropathy, adiposity and insulin secretion in American Indians.Systems biology of kidney diseases.Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND)Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy.Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritisTwenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney DiseaseIdentification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli.A transcriptional blueprint for human and murine diabetic kidney diseaseIntegrative Biology of Diabetic Kidney DiseaseEffects of a GSK-3β inhibitor on the renal expression levels of RANK, RANKL and NF-κB in a rat model of diabetic nephropathy.Cyclodextrin protects podocytes in diabetic kidney disease.Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.
P2860
Q26769678-C69A127A-7960-426F-95C9-0A7AE4A1D080Q26799443-4631A166-0B23-4EAE-8896-DB31006E00A5Q26823206-DA64BB4E-195B-4576-98CF-E2B78943BD05Q26825424-50639F02-65B9-478A-9A6B-2A879A717F4AQ27003963-DAAC46D5-5DD0-4078-BB3E-FD0C7A396EEFQ28086840-E6BCAB2C-FD2A-4A66-98B9-87BEDB0BF73CQ28482696-7B3AA9B2-078E-4439-B9B2-C5895192B1AFQ28483660-3B2855EE-C1F4-49C8-9BFF-58365F6022DAQ28541530-D184C8A9-639D-49BB-A3DE-20DC576583BCQ29417066-5219944D-4750-422E-B6DA-C515F484DB00Q30500731-914C791D-DAF9-4193-8AA4-522ADDC74E31Q33694240-2AF86F67-9C86-4E0D-B01E-0BAEBF9C8D89Q33744411-F2809C35-6D46-4D58-B40B-8AE127723AE3Q33744838-B0F71FED-5CCB-45D2-97A4-0FCA7E3122EFQ33748559-CFD13E27-A551-4A30-8D6C-3522DB20BCDBQ33789303-2E72BC09-A5EC-4566-B959-578F02DFA23FQ33816800-9CF040AD-29C7-4679-93E6-C07EC80B52F3Q33821186-2366B0D2-2846-4448-AB85-A9B2F07AC875Q33999815-FF8E0F14-E5A8-46E1-A20E-08FB028ED2C2Q34023543-9E429760-A2E7-4EAD-90A9-D828F441ED70Q34340510-F48C6EBE-A3EA-4424-9BE2-C16C80F2D0FCQ34343895-4D19337C-38B5-43F2-B56A-A79A976F7CAAQ34391213-59C1C879-1C4E-4A60-AEFD-7CCB4EA9DB2EQ34754640-115910E7-660F-4001-B310-DFE39B7FD877Q34787780-A1CD6533-8EFB-46A6-AA90-D0EC3A610333Q35180096-13F4D960-7A29-4AAA-A9F9-F54E1D22FC49Q35507969-242BCFD6-7E18-4E2B-B144-0DA2CB1FCA2CQ35558848-C05A296C-567D-4550-9FB1-C3FB66BB8555Q35619034-E25A5F30-7D54-47FB-8C51-9828DEA648DFQ35754934-43A57132-FE52-4CD2-A21D-BF86A811CB06Q35804146-167E9F2C-3ADC-4F16-8CA8-8B9970B01274Q36083938-EC88AE7D-781B-4E64-92C7-79326F9DCC6CQ36297539-3B42216F-83B8-42FC-93A5-A14D0E2EA31FQ36462205-AA0BA316-6713-4671-B3AD-5AE1AD11F3C6Q36477207-1D1F7BDD-1F1A-442C-9A36-0F6C81C8AAEBQ36477281-131AD246-B05D-49A1-8AB0-CAEEB2B865F8Q36623841-487EEBBE-9FB7-405F-951E-A1D9FD297791Q36953281-E53C1F86-D0A6-4747-933B-8504E052D721Q37251166-56F69F4B-923D-4CA5-98F9-05EAF3ABFC8DQ37253944-4DBE09D2-D253-4116-A061-794670EFFB76
P2860
Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Enhanced expression of Janus k ...... in human diabetic nephropathy.
@en
Enhanced expression of Janus k ...... in human diabetic nephropathy.
@nl
type
label
Enhanced expression of Janus k ...... in human diabetic nephropathy.
@en
Enhanced expression of Janus k ...... in human diabetic nephropathy.
@nl
prefLabel
Enhanced expression of Janus k ...... in human diabetic nephropathy.
@en
Enhanced expression of Janus k ...... in human diabetic nephropathy.
@nl
P2093
P2860
P356
P1433
P1476
Enhanced expression of Janus k ...... in human diabetic nephropathy.
@en
P2093
Anissa Boucherot
Anna Henger
Celine C Berthier
Christin Carter-Su
Clemens D Cohen
Frank C Brosius
Hongyu Zhang
Lawrence S Argetsinger
Maria P Rastaldi
P2860
P304
P356
10.2337/DB08-1328
P407
P577
2008-11-18T00:00:00Z